Fresenius Medical Care

Update in progress

FMS (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Care Facilities

Fresenius Medical Care AG provides dialysis and related services for kidney disease patients in Germany, the United States, and worldwide. It runs outpatient dialysis clinics offering treatment, laboratory and diagnostic services, patient education, and home-delivery of supplies, plus hospital contracts for inpatient dialysis and acute kidney injury care. It designs and sells dialysis machines, solutions, and related products, and develops renal drugs. Headquartered in Bad Homburg, Germany.

Company score

Sentiment: 0.34; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.08; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.20; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.05; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.10; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.22; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive